Orapred is a brand of corticosteroid medication formulated as an ophthalmic suspension. It is used to treat inflammation and allergic reactions of the eye. The active ingredient is prednisolone acetate, a synthetic glucocorticoid. Orapred works by entering eye cells and binding to intracellular glucocorticoid receptors. This receptor-drug complex then translocates to the nucleus and modulates gene expression. The resulting change in protein synthesis reduces the production of inflammatory mediators. The overall effect is a decrease in redness, swelling, itching, and other signs of ocular inflammation.

Orapred is a synthetic glucocorticoid medication used in therapy. It is employed to reduce inflammation and calm an overactive immune system. The drug binds to intracellular glucocorticoid receptors and changes gene activity. This action suppresses the production of inflammatory signaling molecules. The resulting decrease in inflammation provides its therapeutic anti-inflammatory effect. Orapred modulates stress-related pathways and cellular metabolism. It exerts its influence solely through the glucocorticoid receptor without directly stimulating other receptors. Through these pathways Orapred effectively regulates immune responses and tissue reactions.

Orapred may cause increased appetite and weight gain. It can also lead to mood changes such as irritability or anxiety. Some people experience trouble sleeping. Elevated blood pressure or blood sugar levels have been reported. Occasional stomach discomfort or nausea may occur. These effects are generally mild and temporary.

Common side effects of Orapred include increased appetite and weight gain. Mood changes such as irritability or euphoria may occur. Difficulty sleeping can be experienced by some users. Elevated blood pressure and blood sugar levels are possible reactions. Gastrointestinal discomfort like stomach upset or nausea may appear. Long-term use can also affect bone density.